Drug-Price Debate Targets Pharmacy Benefit Managers

(By Michael Ollove for Stateline an initiative of The Pew Charitable Trusts)

In the bipartisan drive to control prescription drug prices, state and federal lawmakers are taking aim at a new target: pharmacy benefit managers.

PBMs, as the managers are known, are big businesses themselves. The companies negotiate with drug manufacturers on behalf of government health plans and private and employer-based insurance plans. The deals they strike determine the availability and prices of prescription drugs for more than 266 million Americans.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.